Research Library

 
Your search returned 54 results
 
 
 
 
Product

The disproportionate burdens of the mifepristone REMS

As long as the FDA’s Risk Evaluation and Mitigation Strategy (REMS) for mifepristone remain in place, it creates an unnecessary barrier to access safe medication for abortion and miscarriage care. This article discusses why it’s critical to permanently remove the REMS to reduce the disproportionate harms of abortion restrictions on communities of color, and advance equity in and access to timely and essential reproductive health care.

Product Type: 
 
 
Product

Office-Based Surgery Laws

This legal map shows laws that regulate various aspects of non-hospital facilities that provide office-based surgery, procedures and/or anesthesia/sedation.

Product Type: 
 
Product

Procedural Protections in Reproductive Health Care Conscience Laws

This legal map identifies the procedural protections established by laws and regulations in all 50 states and the District of Columbia that protect the conscience rights of health care providers in the context of reproductive health care services, with a particular emphasis on immunity from civil liability and limitations on provider rights in cases where patients are likely to be harmed. It captures the relevant features of laws in effect as of December 2019.

Product Type: 
 
News
 
News
 

Pages